Abstract
Purpose
A randomized trial was initiated to investigate whether a reduction of the dose to the elective nodal sites would result in less toxicity and improvement in Quality of Life (QoL) without compromising tumor control. This paper aimed to compare QoL in both treatment arms.
Methods
Two-hundred head and neck cancer patients treated with radiotherapy (RT) or chemo-RT were randomized (all stages, mean age: 60 years, M/F: 82%/18%). The elective nodal volumes of patients randomized in the experimental arm were treated up to a 40 Gy equivalent dose. In the standard arm, the elective nodal volumes were treated up to a 50 Gy equivalent dose. The QoL data were collected using The European Organization for Research and Treatment of Cancer (EORTC) core questionnaire QLQ-C30 and the EORTC Head and Neck Cancer module (H&N35).
Results
A trend toward less decline in QoL during treatment was observed in the 40 Gy arm compared to the 50 Gy arm. Statistically significant differences for global health status, physical functioning, emotional functioning, speech problems, and trouble with social eating in favor of the 40 Gy arm were observed. A clinically relevant better outcome in the 40 Gy arm was found for physical functioning at the end of therapy.
Conclusion
QoL during RT for head and neck cancer tends to be less impaired in the 40 Gy arm. However, reducing the dose only on the elective neck does not result in clinically relevant improvement of QoL. Therefore, additional treatment strategies must be examined to further improve the QoL of HNSCC patients.
Similar content being viewed by others
References
Grégoire, V., Langendijk, J. A., & Nuyts, S. (2015). Advances in radiotherapy for head and neck cancer. Journal of Clinical Oncology, 33(29), 3277–3284. https://doi.org/10.1200/JCO.2015.61.2994.
Bourhis, J., Overgaard, J., Audry, H., Ang, K. K., Saunders, M., Bernier, J., et al. (2006). Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. The Lancet, 368(938), 843–854. https://doi.org/10.1016/S0140-6736(06)69121-6.
Blanchard, P., Baujat, B., Holostenco, V., Bourredjem, A., Baey, C., Bourhis, J., et al., …, MACH-CH Collaborative Group. (2011). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site. Radiotherapy and Oncology, 100(1), 33–40. https://doi.org/10.1016/j.radonc.2011.05.036.
Nuyts, S., Dirix, P., Clement, P. M. J., Vander Poorten, V., Delaere, P., Schoenaers, J., et al. (2009). Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma. International Journal of Radiation Oncology, Biology, Physics, 73(4), 1088–1095. https://doi.org/10.1016/j.ijrobp.2008.05.042.
Machtay, M., Moughan, J., Trotti, A., Garden, A. S., Weber, R. S., Cooper, J. S., …, Ang, K. K. (2008). Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. Journal of Clinical Oncology, 26(21), 3582–3589. https://doi.org/10.1200/JCO.2007.14.8841.
Langendijk, J. A., Doornaert, P., Verdonck-de Leeuw, I. M., Leemans, C. R., Aaronson, N. K., & Slotman, B. J. (2008). Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. Journal of Clinical Oncology, 26(22), 3770–3776. https://doi.org/10.1200/JCO.2007.14.6647.
Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., et al. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. The Lancet Oncology, 12(2), 127–136. https://doi.org/10.1016/S1470-2045(10)70290-4.
Langendijk, J. A., Doornaert, P., Rietveld, D. H. F., Verdonck-de Leeuw, I. M., Leemans, C. R., & Slotman, B. J. (2009). A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiotherapy and Oncology, 90(2), 189–195. https://doi.org/10.1016/j.radonc.2008.12.017.
Dirix, P., Abbeel, S., Vanstraelen, B., Hermans, R., & Nuyts, S. (2009). Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: Dose-effect relationships for the swallowing structures. International Journal of Radiation Oncology, Biology, Physics, 75(2), 385–392. https://doi.org/10.1016/j.ijrobp.2008.11.041.
Levendag, P. C., Teguh, D. N., Voet, P., van der Est, H., Noever, I., de Kruijf, W. J. M., …, Heijmen, B. J. (2007). Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiotherapy and Oncology, 85(1), 64–73. https://doi.org/10.1016/j.radonc.2007.07.009.
Christianen, M. E. M. C., Schilstra, C., Beetz, I., Muijs, C. T., Chouvalova, O., Burlage, F. R., …, Langendijk, J. A. (2012). Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study. Radiotherapy and Oncology, 105(1), 107–114. https://doi.org/10.1016/j.radonc.2011.08.009.
Feng, F. Y., Kim, H. M., Lyden, T. H., Haxer, M. J., Worden, F. P., Feng, M., …, Eisbruch, A. (2010). Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. Journal of Clinical Oncology, 28(16), 2732–2738. https://doi.org/10.1200/JCO.2009.24.6199.
Maccomb, W. S., & Fletcher, G. H. (1957). Planned combination of surgery and radiation in treatment of advanced primary head and neck cancers. The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine, 77(3), 397–414.
Nuyts, S., Lambrecht, M., Duprez, F., Daisne, J.-F., Van Gestel, D., Van den Weyngaert, D., … De Neve, W. (2013). Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity. Radiotherapy and Oncology, 109(2), 323–329. https://doi.org/10.1016/j.radonc.2013.06.044
Nevens, D., Duprez, F., Daisne, J. F., Dok, R., Belmans, A., Voordeckers, M., … Nuyts, S. (2017). Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control. Radiotherapy and Oncology, 122(2), 171–177. https://doi.org/10.1016/j.radonc.2016.08.009
Nevens, D., Duprez, F., Daisne, J.-F., Schatteman, J., Van der Vorst, A., De Neve, W., et al. (2017). Recurrence patterns after a decreased dose of 40Gy to the elective treated neck in head and neck cancer. Radiotherapy and Oncology, 123(3), 419–423. https://doi.org/10.1016/j.radonc.2017.03.003.
Deschuymer, S., Nevens, D., Duprez, F., Daisne, J.-F., Dok, R., Laenen, A., …, Nuyts, S. (2020). Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome. Radiotherapy and Oncology, 143, 24–29. https://doi.org/10.1016/j.radonc.2020.01.005.
Grégoire, V., Eisbruch, A., Hamoir, M., & Levendag, P. (2006). Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiotherapy and Oncology, 79(1), 15–20. https://doi.org/10.1016/j.radonc.2006.03.009.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., …, de Haes, J. C. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.
Bjordal, K., Hammerlid, E., Ahlner-Elmqvist, M., de Graeff, A., Boysen, M., Evensen, J. F., …, Kaasa, S. (1999). Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. Journal of Clinical Oncology, 17(3), 1008–1019. https://doi.org/10.1200/JCO.1999.17.3.1008.
Singer, S., Wollbrück, D., Wulke, C., Dietz, A., Klemm, E., Oeken, J., …, Schwarz, R. (2009). Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery. Head & Neck, 31(1), 64–76. https://doi.org/10.1002/hed.20938.
Singer, S., Arraras, J. I., Chie, W.-C., Fisher, S. E., Galalae, R., Hammerlid, E., …, Hofmeister, D. (2013). Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: A methodological review. Quality of Life Research, 22(8), 1927–1941. https://doi.org/10.1007/s11136-012-0325-1.
Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., Bottomley, A. & On behalf of the EORTC Quality of Life Group. (2001). The EORTC QLQ-C30 Scoring Manual (3rd Edition). Brussels: European Organisation for Research and Treatment of Cancer.
Cocks, K., King, M. T., Velikova, G., Martyn St-James, M., Fayers, P. M., & Brown, J. M. (2011). Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Journal of Clinical Oncology, 29(1), 89–96. https://doi.org/10.1200/JCO.2010.28.0107.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144. https://doi.org/10.1200/JCO.1998.16.1.139.
Scott, N. W., Fayers, P. M., Aaronson, N. K., Bottomley, A., Graeff, A., Groenvold, M., Gundy, C., Koller, M., Petersen, M. A., Mirjam A. G., & Sprangers on behalf of the EORTC Quality of Life Group. (2008). EORTC QLQ-C30 Reference values manual. Brussels. EORTC Quality of Life Group Publications.
Bottomley, A., Tridello, G., Coens, C., Rolland, F., Tesselaar, M. E. T., Leemans, C. R., …, Lefebvre, J.-L. (2014). An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group. Cancer, 120(3), 390–398. https://doi.org/10.1002/cncr.28392.
de Graeff, A., de Leeuw, J. R., Ros, W. J., Hordijk, G. J., Blijham, G. H., & Winnubst, J. A. (2000). Long-term quality of life of patients with head and neck cancer. The Laryngoscope, 110(1), 98–106. https://doi.org/10.1097/00005537-200001000-00018.
Curran, D., Giralt, J., Harari, P. M., Ang, K. K., Cohen, R. B., Kies, M. S., …, Bonner, J. A. (2007). Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. Journal of Clinical Oncology, 25(16), 2191–2197. https://doi.org/10.1200/JCO.2006.08.8005.
Vainshtein, J. M., Moon, D. H., Feng, F. Y., Chepeha, D. B., Eisbruch, A., & Stenmark, M. H. (2015). Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer. International Journal of Radiation Oncology, Biology, Physics, 91(5), 925–933. https://doi.org/10.1016/j.ijrobp.2014.12.045.
Meirovitz, A., Murdoch-Kinch, C. A., Schipper, M., Pan, C., & Eisbruch, A. (2006). Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 66(2), 445–453. https://doi.org/10.1016/j.ijrobp.2006.05.002.
Kaae, J. K., Johnsen, L., Hansen, C. R., Kristensen, M. H., Brink, C., & Eriksen, J. G. (2019). Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy. Acta oncologica (Stockholm, Sweden), 58(10), 1366–1372. https://doi.org/10.1080/0284186X.2019.1627413.
de Veij Mestdagh, P. D., Jonker, M. C. J., Vogel, W. V., Schreuder, W. H., Donswijk, M. L., Klop, W. M. C., et al. (2018). SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology, 275(8), 2135–2144. https://doi.org/10.1007/s00405-018-5050-0.
de Veij Mestdagh, P. D., Schreuder, W. H., Vogel, W. V., Donswijk, M. L., van Werkhoven, E., van der Wal, J. E., …, Al-Mamgani, A. (2019). Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): A single-center prospective trial. BMC Cancer, 19(1), 1110. https://doi.org/10.1186/s12885-019-6331-8.
Daisne, J.-F., Installé, J., Bihin, B., Laloux, M., Vander Borght, T., Mathieu, I., et al. (2014). SPECT/CT lymphoscintigraphy of sentinel node(s) for superselective prophylactic irradiation of the neck in cN0 head and neck cancer patients: A prospective phase I feasibility study. Radiation Oncology, 9, 121. https://doi.org/10.1186/1748-717X-9-121.
Blanchard, P., Garden, A. S., Gunn, G. B., Rosenthal, D. I., Morrison, W. H., Hernandez, M., …, Frank, S. J. (2016). Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer—a case matched analysis. Radiotherapy and Oncology, 120(1), 48–55. https://doi.org/10.1016/j.radonc.2016.05.022.
Bottomley, A., Flechtner, H., Efficace, F., Vanvoorden, V., Coens, C., Therasse, P., et al. (2005). Health related quality of life outcomes in cancer clinical trials. European Journal of Cancer, 41(12), 1697–1709. https://doi.org/10.1016/j.ejca.2005.05.007.
Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., et al., …, Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) consortium. (2016). Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: A start in setting international standards. The Lancet Oncology, 17(11), e510–e514. https://doi.org/10.1016/S1470-2045(16)30510-1.
Pe, M., Dorme, L., Coens, C., Basch, E., Calvert, M., Campbell, A., Campbell, A., …, Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium (SISAQOL). (2018). Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: A systematic review. The Lancet Oncology, 19(9), e459–e469. https://doi.org/10.1016/S1470-2045(18)30418-2.
Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., …, Coens, C. (2018). Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials. Clinical Trials, 15(6), 624–630. https://doi.org/10.1177/1740774518795637.
Acknowledgements
Study organization and data collection were performed by Rita Aerts. Statistical analysis was done in collaboration with Ann Belmans.
Funding
This project is supported by a grant from Stand up to Cancer (Kom op tegen Kanker), the Flemish Cancer Society.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflicts of interest.
Consent to Participate
All patients gave written informed consent.
Ethical Approval
This study was approved by the local ethics committee (Ethische Commissie Onderzoek UZ/KU Leuven) and was conducted in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Deschuymer, S., Nevens, D., Duprez, F. et al. Randomized Clinical Trial on Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma: Results on the Quality of Life. Qual Life Res 30, 117–127 (2021). https://doi.org/10.1007/s11136-020-02628-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-020-02628-w